Cellectar Biosciences Inc (NAS:CLRB)
$ 0.3052 -0.9748 (-76.16%) Market Cap: 52.83 Mil Enterprise Value: 35.58 Mil PE Ratio: 0 PB Ratio: 33.68 GF Score: 30/100

Cellectar Biosciences Inc Annual Shareholders Meeting Transcript

Jun 23, 2023 / 02:00PM GMT
Release Date Price: $1.86 (-4.12%)
Jim Caruso
Cellectar Biosciences, Inc. - President, CEO & Director

Good morning, and welcome, ladies and gentlemen. It is now 10 AM and this meeting will come to order. I am Jim Caruso, President and Chief Executive Officer of Cellectar Biosciences, Inc. I will be presiding at this annual meeting of our company stockholders.

Also in attendance today is Kevin Chow, Inspector of Elections; and members of the Board of Directors: Mr. Doug Swirsky, our Chairman; Dr. Stefan Loren; Dr. Asher Chanan-Khan; and Mr. John Neis. Our management team is also present as well. And we have a representative from Baker Tilly, Mr. Paul Kinmartin.

The business of this meeting will be conducted in accordance with the rules of conduct, which are available online. Please refer to them as necessary.

Currently, the polls are open. As a reminder, if you have already voted by proxy and do not wish to change your vote, your vote will be cast as previously instructed and no further action is necessary. If anyone has not previously provided a proxy and wish to vote your shares today, or if anyone has

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot